In performance tests involving over four thousand unknown genomes, PathogenFinder2 demonstrated superior predictive accuracy compared to existing genomic surveillance tools. This breakthrough comes at a critical juncture in 2026, as the global community faces an increasingly complex landscape of
The development of B-SYNC is an evolution of the 2021 E-SYNC model, moving from a rare mutant protein trigger to a more universal brain protein to help a broader range of patients. In the current landscape of pediatric medicine, few diagnoses carry as much weight as diffuse midline glioma, an
Faster-growing yeast cells in continuous culture produce enzymes with higher specific activity, suggesting that growth rate directly influences the quality of the final protein product. This discovery marks a pivotal shift in how bioengineers approach the metabolic trade-off between cellular growth
The landscape of influenza infection is characterized by extreme heterogeneity, where many cells fail to produce a complete set of viral genes due to packaging errors. This fundamental challenge means that the survival of a specific viral lineage often depends more on the logistical circumstances
Star Therapeutics is using $200 million in new venture funding to return to early development after two major outcomes for its offshoots. CEO Adam Rosenthal describes the move as a reset, with research now focused on experimental biologics for blood and immune disorders. The strategic shift is as
Domestic life-sciences innovator Basecamp Research will provide niche biological datasets to ensure the lab possesses more than just general-purpose computational tools. The United Kingdom has officially established the AI Biosecurity Lab, a pioneering institution that represents the first